Year: 2024
Type: article
Abstract: Authors´ conclusions: nightly use of 0.05% atropine eyedrops among children aged 4 to 9 years without myopia resulted in a significantly lower incidence of myopia and lower percentage of participants with fast myopic shift at 2 years. Reviewers´ commentary: this study, of adequate design and quality, concludes that atropine in low concentration helps prevent the onset and rapid progression of myopia in high-risk children, with few side effects. Long-term follow-up is pending to assess adequate follow-up time and possible rebound effect after suspension.
DOI: 10.60147/a0e2a88f
Authors: Elena Pérez, Victoria Martínez
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4403042446